ANTISENSE THERAPEUTICS LIMITED
ASX:ANP
Last Capital Raise
Not Available
Not Available
Not Available
Mar 12, 2019
Company Information
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Type
Listed Company
GICS Sub-Industry
Pharmaceuticals
Head Office
6 Wallace Ave, Toorak VIC 3142, Australia
Website
Quarterly Cash Flows
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.